Skip to content

Clinical trials

Withdrawn Medulloblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Medulloblastoma Status: Withdrawn Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20133
20161
20171
20191
20201
20211
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
Sue O'Dorisio2
Children's Oncology Group1
Eli Lilly and Company1
Jeffrey Treiber1
Jiujiang University Affiliated Hospital1
Medical University of South Carolina1
Northwestern University1
Vanderbilt University1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Medulloblastoma13
Ependymoma6
Glioma6
Central Nervous System Neoplasms5
Astrocytoma4
Glioblastoma4
Meningioma4
Neuroectodermal Tumors, Primitive4
Brain Neoplasms3
Choroid Plexus Neoplasms3

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.